ProstaScint 111-Indium capromab pendetide data

Phase III data were released for ProstaScint at the American Urological Association meeting

Read the full 138 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE